Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison

BACKGROUND: Combinations of trastuzumab with either docetaxel or vinorelbine are considered valuable treatment options for HER2-positive metastatic breast cancer patients. We performed a retrospective comparison of the clinical outcomes associated with either one of these combinations. METHODS: From...

Descripción completa

Detalles Bibliográficos
Autores principales: Redana, Stefania, Donadio, Michela, Nolè, Franco, Jacomuzzi, Maria Elena, Beano, Alessandra, Martinello, Rossella, Sapino, Anna, Viale, Giuseppe, Aglietta, Massimo, Montemurro, Filippo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835645/
https://www.ncbi.nlm.nih.gov/pubmed/20122160
http://dx.doi.org/10.1186/1471-2407-10-28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835645/
https://www.ncbi.nlm.nih.gov/pubmed/20122160
http://dx.doi.org/10.1186/1471-2407-10-28

Ejemplares similares